Format

Send to

Choose Destination
Nat Rev Cancer. 2010 Aug;10(8):561-74. doi: 10.1038/nrc2889.

IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.

Author information

1
Biotech Research and Innovation Centre, University of Copenhagen, Ole Maal√łes Vej 5, Copenhagen DK2200, Denmark. mads.gyrd@bric.ku.dk

Abstract

The realization that alterations in inhibitor of apoptosis (IAP) proteins are found in many types of human cancer and are associated with chemoresistance, disease progression and poor prognosis, has sparked a worldwide frenzy in the development of small pharmacological inhibitors of IAPs. The development of such inhibitors has radically changed our knowledge of the signalling processes that are regulated by IAPs. Recent studies indicate that IAPs not only regulate caspases and apoptosis, but also modulate inflammatory signalling and immunity, mitogenic kinase signalling, proliferation and mitosis, as well as cell invasion and metastasis.

PMID:
20651737
DOI:
10.1038/nrc2889
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center